The pharmacological compliance has been over 95% in
Percentage of patients that have improved their level related to the base treatment in the first six months after start using Medtep Asthma.
A quarter of the total patients have decreased their treatment dose since the beginning of the pilot study.
By the decrease of medical visits, emergency health services and hospital admissions, Medtep Asthma may contribute up to 10% annual cost reduction per patient1.
1 Martínez E, Serra J, De Diego A, et al. Economic Cost of Treating the Patient With Asthma in Spain: The AsmaCost Study. 2009; 45(10):481-486[Arch Bronconeumol]
Currently we have no open positions available.
Actualmente no tenemos vacantes disponibles.